RAPGEF3 and melanoma: Epac mediates cell adhesion in Ovcar3 cells [13], apoptosis and growth arrest [14] in B lymphoma cells, formation of embryonic vasculogenic networks in melanoma cells [16], and proliferation of prostate carcinoma cells [15].